Palisade Capital Expands Portfolio With New Bets

36 sourcesUpdated Aug 26, 2026

In Q2 2026, Palisade Capital Management LP disclosed new positions in four companies: OneSpaWorld Holdings (OSW), Quaker Houghton (KWR), Corsair Gaming (CRSR), and Palisade Bio (PALI). Palisade bought 615,522 OSW shares valued at about $17.38 million, representing roughly 0.61% of the company, while OSW and related performance metrics point to a broader institutional activity in the stock. The firm acquired 53,733 shares of KWR, worth about $8.54 million, as part of a wave of secondary stake activity from other investors in the quarter. In Corsair Gaming, Palisade bought 559,151 shares valued around $5.41 million, with institutional ownership among rivals also shifting notably during the period. Palisade’s new stake in Palisade Bio consisted of 1,726,662 shares valued at about $3.61 million, reflecting continued interest in the biotech name from large investors. Overall, the quarter saw multiple large funds, including Legal & General, Manufacturers Life, BNP Paribas, and JPMorgan Chase, adjusting positions in these names, indicating broad appetite for this cohort of equities.

In this story:

Q2 2026 institutional 13F filings reveal fresh stock stakesstory 10 of 11 · since Aug 23, 2026

Aug 23, 2026Aug 26, 2026

Aug 26, 2026Palisade Capital Management discloses new Q2 stakes in OneSpaWorld Holdings, Quaker Houghton, Corsair Gaming and Palisade Bio.
Aug 26, 2026PDT Partners discloses new Q2 stakes in Frontdoor, Westlake Corporation, Reliance, Arcus Biosciences and Pilgrim's Pride worth in the millions.
Aug 26, 2026ADAR1 Capital Management discloses new Q2 stakes in five biopharma companies, including ACADIA Pharmaceuticals and Larimar Therapeutics, worth up to about $1.9 million each.